These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1259789)

  • 1. Altered pattern of dopa metabolism.
    Fellman JH; Roth ES; Heriza EL; Fujita TS
    Biochem Pharmacol; 1976 Jan; 25(2):222-3. PubMed ID: 1259789
    [No Abstract]   [Full Text] [Related]  

  • 2. Transamination is a major pathway of L-dopa metabolism following peripheral decarboxylase inhibition.
    Sandler M; Johnson RD; Ruthven CR; Reid JL; Calne DB
    Nature; 1974 Feb; 247(5440):364-6. PubMed ID: 4817854
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). VI. Metabolism of D-DOPA in rat kidney.
    Shindo H; Maeda T
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1721-31. PubMed ID: 4154147
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbidopa attenuation of L-DOPA emesis in dogs: evidence for a cerebral site of action outside the blood-brain barrier.
    Lotti VJ; Clark C
    Eur J Pharmacol; 1974 Mar; 25(3):322-5. PubMed ID: 4827858
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of benserazide and carbidopa on the metabolism of L-tryptophan by isolated rat liver cells.
    Smith SA; Pogson CI
    Biochem Pharmacol; 1981 Mar; 30(6):623-8. PubMed ID: 7271899
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of hepatic aldehyde dehydrogenase by carbidopa.
    Messiha FS
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):601-4. PubMed ID: 674836
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney.
    Suzuki H; Nakane H; Kawamura M; Yoshizawa M; Takeshita E; Saruta T
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E285-90. PubMed ID: 6433718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa.
    Airoldi L; Watkins CJ; Wiggins JF; Wurtman RJ
    Metabolism; 1978 Jul; 27(7):771-9. PubMed ID: 661563
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfer of DOPA from the sympatho-adrenal system to the pancreas, liver and kidney via the blood circulation.
    Andén NE; Grabowska-Andén M; Schwieler J
    Acta Physiol Scand; 1989 May; 136(1):75-9. PubMed ID: 2570506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of aspirin (acetyl salicylate) on macromolecule turnover in rat kidney and liver.
    Wheldrake JF
    Experientia; 1975 May; 31(5):559-60. PubMed ID: 1140254
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa).
    Joseph MH; Hall-Tipping DL
    Biochem Soc Trans; 1978; 6(5):997-1000. PubMed ID: 744365
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
    Vogel WH; Mahoney K; Hare TA
    Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of long-term infusions of dopa and carbidopa on renin and steroid secretion in the rat.
    Inglis GC; Kenyon CJ
    Endocrinology; 1992 Dec; 131(6):2941-5. PubMed ID: 1446631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carbidopa on the metabolism of L-dopa in the pigtail monkey.
    Bronaugh RL; Wenger GR; Garver DL; Rutledge CO
    Biochem Pharmacol; 1976 Jul; 25(14):1679-81. PubMed ID: 821489
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of DOPA-2- 14 C in relation to DOPA-1- 14 C (carboxyl- 14 C-labelled DOPA) in mice before and after inhibition of DOPA-decarboxylase, studied by whole-body autoradiography.
    Tjälve H; Ullberg S
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):376-88. PubMed ID: 4627124
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of human and rat hepatic aminotransferase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase.
    Waterhouse MJ; Chia YC; Lees GJ
    Mol Pharmacol; 1979 Jan; 15(1):108-14. PubMed ID: 423884
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbidopa elevates hypothalamic dopa and serum prolactin in rats.
    Watkins CJ; Wiggins JF; Wurtman RJ
    Life Sci; 1979 Apr; 24(18):1675-82. PubMed ID: 481101
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of nacom (L-dopa and L-carbidopa) on growth hormone secretion in 75 patients with short stature.
    Schönberger W; Grimm W; Ziegler R
    Eur J Pediatr; 1977 Dec; 127(1):15-9. PubMed ID: 606555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.